BETARC betahistine dihydrochloride 16mg tablets blister pack 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

betarc betahistine dihydrochloride 16mg tablets blister pack

medis pharma pty ltd - betahistine dihydrochloride, quantity: 16 mg - tablet - excipient ingredients: lactose monohydrate; crospovidone; povidone; microcrystalline cellulose; stearic acid; colloidal anhydrous silica - meniere?s syndrome as defined by the following core symptoms: ,- vertigo (with nausea/vomiting) ,- hearing loss (hardness of hearing) ,- tinnitus

BETAHISTAVERT betahistine dihydrochloride 16 mg tablets blister packs 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

betahistavert betahistine dihydrochloride 16 mg tablets blister packs

arrotex pharmaceuticals pty ltd - betahistine dihydrochloride, quantity: 16 mg - tablet, uncoated - excipient ingredients: citric acid; microcrystalline cellulose; mannitol; purified talc; colloidal anhydrous silica - meniere's syndrome as defined by the following core symptoms: vertigo (with nausea/vomiting), hearing loss (hardness of hearing) and tinnitus.

BETISTAVERT betahistine dihydrochloride 16 mg tablets blister packs 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

betistavert betahistine dihydrochloride 16 mg tablets blister packs

arrotex pharmaceuticals pty ltd - betahistine dihydrochloride, quantity: 16 mg - tablet, uncoated - excipient ingredients: purified talc; colloidal anhydrous silica; microcrystalline cellulose; mannitol; citric acid - meniere's syndrome as defined by the following core symptoms: vertigo (with nausea/vomiting), hearing loss (hardness of hearing) and tinnitus.

SERBEHIST betahistine dihydrochloride 16 mg tablets blister packs 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

serbehist betahistine dihydrochloride 16 mg tablets blister packs

arrotex pharmaceuticals pty ltd - betahistine dihydrochloride, quantity: 16 mg - tablet, uncoated - excipient ingredients: citric acid; colloidal anhydrous silica; purified talc; mannitol; microcrystalline cellulose - meniere's syndrome as defined by the following core symptoms: vertigo (with nausea/vomiting), hearing loss (hardness of hearing) and tinnitus.

BEHISTATINE betahistine dihydrochloride 16 mg tablets blister packs 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

behistatine betahistine dihydrochloride 16 mg tablets blister packs

arrotex pharmaceuticals pty ltd - betahistine dihydrochloride, quantity: 16 mg - tablet, uncoated - excipient ingredients: mannitol; microcrystalline cellulose; colloidal anhydrous silica; purified talc; citric acid - meniere's syndrome as defined by the following core symptoms: vertigo (with nausea/vomiting), hearing loss (hardness of hearing) and tinnitus

SERBEHISTIN betahistine dihydrochloride 16 mg tablets blister packs 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

serbehistin betahistine dihydrochloride 16 mg tablets blister packs

arrotex pharmaceuticals pty ltd - betahistine dihydrochloride, quantity: 16 mg - tablet, uncoated - excipient ingredients: colloidal anhydrous silica; purified talc; microcrystalline cellulose; mannitol; citric acid - meniere's syndrome as defined by the following core symptoms: vertigo (with nausea/vomiting), hearing loss (hardness of hearing) and tinnitus.

BETAHIST betahistine dihydrochloride 16 mg tablets blister packs 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

betahist betahistine dihydrochloride 16 mg tablets blister packs

arrotex pharmaceuticals pty ltd - betahistine dihydrochloride, quantity: 16 mg - tablet, uncoated - excipient ingredients: purified talc; colloidal anhydrous silica; mannitol; citric acid; microcrystalline cellulose - meniere's syndrome as defined by the following core symptoms: vertigo (with nausea/vomiting), hearing loss (hardness of hearing) and tinnitus.

BETASTINE betahistine dihydrochloride 16 mg tablets blister packs 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

betastine betahistine dihydrochloride 16 mg tablets blister packs

gm pharma international pty ltd - betahistine dihydrochloride, quantity: 16 mg - tablet, uncoated - excipient ingredients: colloidal anhydrous silica; citric acid; microcrystalline cellulose; purified talc; mannitol - meniere's syndrome as defined by the following core symptoms: vertigo (with nausea/vomiting), hearing loss (hardness of hearing) and tinnitus.

Betahistine Dihydrochloride Tablets 16mg 몰타 - 영어 - Medicines Authority

betahistine dihydrochloride tablets 16mg

pharmacare premium limited hhf 003 halfar industrial estate birzebbugia bbg 3000, malta - betahistine dihydrochloride - tablet - betahistine dihydrochloride 16 mg - other nervous system drugs

Arrow - Betahistine 뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

arrow - betahistine

teva pharma (new zealand) limited - betahistine dihydrochloride 16mg - tablet - 16 mg - active: betahistine dihydrochloride 16mg excipient: citric acid crospovidone hydrogenated vegetable oil lactose monohydrate maize starch microcrystalline cellulose povidone - meniere's syndrome as defined by the following core symptoms: - vertigo (with nausea/vomiting) - hearing loss (hardness of hearing) - tinnitus